Search results
Results From The WOW.Com Content Network
House Bill 136 in the 2022 session would have created a medical cannabis program. It was passed by the house of representatives 59–34 on March 17, 2022. [1]The governor of Kentucky, Andy Beshear, said on April 7, 2022, that he was considering executive action to permit medical cannabis in his state if House Bill 136 was not approved in the state senate. [2]
In January 2023, an executive order signed by Gov. Andy Beshear began allowing qualifying Kentuckians with chronic conditions to use medical marijuana. And by 2025, Kentucky’s new medical ...
The Kentucky Medical Cannabis Program — which regulates the legal cultivation, production, sale and use of medical marijuana products — is set to officially start Jan. 1, 2025.
Medical marijuana cardholders in Kentucky will be able to use the products starting Jan. 1, 2025, and the program’s executive director says dispensaries should be a relatively short drive away ...
In 2015, House Bill 3 and Senate Bill 40 both proposed establishing a medical cannabis framework in Kentucky; both failed to pass out of committee. The anti-cannabis National Marijuana Initiative and the Kentucky Baptist Convention took credit for the defeat of the bills, and vowed to oppose medical cannabis bills in 2016. NMI coordinator Ed ...
Although Trump indicated during his 2016 presidential campaign that he favored leaving the issue of legalization of marijuana to the states, his administration subsequently upheld the federal prohibition of cannabis, and Trump's 2021 fiscal budget proposal included removing protections for state medical marijuana laws. [1]
In March, Gov. Andy Beshear signed Senate Bill 47, which legalizes medical marijuana. It will go into effect in 2025 after more than a decade of failed attempts. Under the law, patients with at ...
Timeline of Gallup polls in US on legalizing marijuana. [1]In the United States, cannabis is legal in 39 of 50 states for medical use and 24 states for recreational use. At the federal level, cannabis is classified as a Schedule I drug under the Controlled Substances Act, determined to have a high potential for abuse and no accepted medical use, prohibiting its use for any purpose. [2]